ReviewObesity surgery2026
Prevention and Management of Recurrent Weight Gain After Bariatric Surgery: Integrating Behavioural, Pharmacological and Procedural Approaches.
Review in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recurrent weight gain (RWG) after bariatric surgery leads to a suboptimal clinical response for many patients, challenging long-term outcomes. This narrative review focuses on evidence-based strategies for the prevention and management of this multifactorial challenge. Successful persistent outcomes rely on proactive, structured multidisciplinary follow-up to enable early detection of weight trajectories and timely, tiered intervention. Initial treatment involves intensive nutritional and behavioral therapy, including cognitive behavioral techniques. When insufficient, pharmacological adjuncts, notably GLP-1 receptor agonists, demonstrate efficacy. Endoscopic revision and surgical revision or conversion are reserved for anatomical causes or refractory cases. A tailored integration of behavioral, pharmacological, and procedural strategies is essential to sustain metabolic health and durable weight control.
Indexed as
Identifiers
42191978What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.